Granules India to focus on R&D and formulations

15 Jul 2015 Evaluate

Granules India is planning to focus on Research and Development (R&D) and formulations. Moreover, the company may look at acquiring companies having high technology in formulations manufacturing or with a sizable formulations portfolio. The company would like to make 1-2 acquisitions preferably in the US and in India if it could find a right company.

Granules India is a fast growing pharmaceutical manufacturing company with world class facilities and is committed to manufacturing excellence, quality and customer service. The Company produces Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs) for quality conscious customers in the regulated and semi-regulated markets.

 

Granules India Share Price

564.95 -6.25 (-1.09%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×